Navigation Links
FDA Grants 510(k) Clearance for Innovative Fuse Gastroscope from EndoChoice
Date:10/28/2013

ATLANTA, Oct. 28, 2013 /PRNewswire/ -- Now doctors performing flexible endoscopy have a new tool available to help them see more anatomy and facilitate diagnoses in the upper GI tract. Traditional gastroscopes that have been available to endoscopists provide a field of view limited to about 140 degrees. EndoChoice® today announced the FDA had provided 510(k) clearance of its new Fuse™ Gastroscope that has a field of view of 245 degrees. Endoscopes are thin flexible tubes with imaging capabilities that doctors use to view the upper and lower GI tracts of their patients.

EndoChoice engineers have developed a proprietary, new method of designing and manufacturing flexible circuits that allow them to put more small cameras on the tips of flexible endoscopes. This new concept of Full Spectrum Endoscopy™ is changing the field of endoscopy where significant improvements in technology have not occurred in more than 20 years. The new gastroscope joins the revolutionary, endoscopy system line of products released earlier this year by EndoChoice under the Fuse brand. The Fuse Gastroscope has two cameras and the Fuse Colonoscope has three cameras while traditional systems have just one camera.

The Fuse system allows doctors to see nearly twice as much surface area as they can with traditional endoscopes. Because of the folds that occur naturally in the colon and stomach anatomy, problem areas can easily go undetected when using traditional endoscopes. The Fuse system allows GI doctors to see into and behind those folds. The images of the anatomy are displayed on high-definition screens specially arranged to give the doctor a full spectrum view.

Data supporting the Fuse system were presented simultaneously at the American College of Gastroenterology Annual Scientific Session last week in San Diego, California, and at the Union European Gastroenterology Week in Berlin, Germany. Researchers demonstrated the ability to see more with the Fuse system has a statistically significant impact on their ability to find adenomas or precancerous lesions when compared to traditional single-view endoscopes. "We have a national colorectal cancer screening program in the United States wherein most people should get screened for colorectal cancer, but not all patients follow these guidelines. The data from the Full Spectrum Endoscopy Tandem study would indicate that Fuse is a radical improvement over the tools we've used in the past to fight GI disease," said Douglas K. Rex, Professor of Medicine at Indiana University.

"We are 100% focused on serving the GI professionals so they can give the best possible care to their patients," said Mark Gilreath, Founder and CEO at EndoChoice. "This clearance by the FDA is yet another milestone in our efforts to make the Fuse system available to more hospitals and clinics."

About EndoChoice

Based in Atlanta, EndoChoice is a platform GI company that provides devices, diagnostics, infection control and imaging for specialists treating a wide range of gastrointestinal diseases. EndoChoice currently has over 2,000 customers and distribution in 34 countries worldwide, and has been recognized for four consecutive years as one of the fastest growing companies in the U.S. by Inc. Magazine. To learn more, visit www.endochoice.com.

EndoChoice and Fuse™ are trademarks of EndoChoice, Inc

For more information, press only:

Doug Ladd, Chief Marketing Officer
513-608-6873 or Doug.Ladd@endochoice.com

For more information on Fuse™

www.endochoice.com/fuse


'/>"/>
SOURCE EndoChoice
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Philanthropic Grants, Product Launches, Promising Partnerships, and Customer Satisfaction Rankings - Research Report on CVS Caremark, Walgreens, McKesson, AmerisourceBergen, and Cardinal Health
2. Life Technologies Awards Digital PCR Innovation Grants to Five Research Labs
3. FDA Grants Lillys Ramucirumab Priority Review as a Potential Single-Agent Treatment for Advanced Gastric Cancer
4. FDA Grants Orphan Drug Designation to Omeros OMS824 for Huntingtons Disease
5. European Union Grants a Good Manufacturing Practice Certificate to Nelson Laboratories
6. The Kenneth Rainin Foundation Continues its Commitment to Ending Inflammatory Bowel Disease, Awarding $1.5 Million in Research Grants
7. FDA Grants Orphan Drug Status To Eisais Investigational Compound (E7777) For Cutaneous T-Cell Lymphoma
8. FDA Grants Priority Review To New Drug Application For MNK-795 Submitted By Depomed Licensee Mallinckrodt
9. Avanir Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
10. Agnitio Grants 10,000 New Licenses Globally this Financial Year
11. FDA Grants Soligenix "Fast Track" Designation for SGX942 for the Treatment of Oral Mucositis in Patients with Head and Neck Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... , July 21, 2017 Did you know that PhRMA ... 2016? Or that combined spending on brand medicines, generics and the ... with brands accounting for just half of this (7 percent)? Or ... thirds of the world,s venture capital investments in high-growth biopharmaceutical startups? ... ...
(Date:7/19/2017)... RALEIGH, N.C. , July 19, 2017  Mako ... Veteran Affairs, and the Military Family Assistance Fund (MFA) ... Louisiana to visit with their families one ... the funding to coordinate the travel and logistics needed ... supporting our deployed soldiers and their families. We just ...
(Date:7/15/2017)... , July 15, 2017 Enterin Inc., a ... treat Parkinson,s disease (PD), today announced the completion of a ... investors New Ventures III, as well as the participation of ... absolutely thrilled to have the support of New Ventures III ... investors as validation of the potential of our platform technology ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... July 21, 2017 , ... In ... researchers from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform ... surgery, though activity levels decline over time. The study, presented today at the ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... concussion rates are on the rise, say researchers presenting their work at the ... Ontario, Canada. , “The combination of evaluating the patterns of change in concussion ...
(Date:7/20/2017)... ... July 20, 2017 , ... ChenMed , a leading provider ... JenCare Senior Medical Center as Richmond Chief Medical Officer. Dr. McCarter, formerly ... Associate Chief Medical Officer of Ambulatory Services for the UVA Health System, brings 30 ...
(Date:7/20/2017)... (PRWEB) , ... July 20, ... ... provider of enterprise-grade IT operations analytics and application performance monitoring (APM) solutions, ... world’s largest healthcare services providers. , According to Peter Ohrenberger, sales director ...
(Date:7/20/2017)... ... July 20, 2017 , ... For individuals with extended ... The adjustable beds used in such facilities are specially designed to accommodate patients with ... support. , An inventor from Rochester, Ind., has invented the patent-pending PORTABLE ARM ...
Breaking Medicine News(10 mins):